No Data
Hinova Pharmaceuticals Inc.'s (SHSE:688302) Market Cap Touched CN¥4.3b Last Week, Benefiting Both Individual Investors Who Own 43% as Well as Institutions
2025 First Quarter Report
Haichuang Pharmaceutical Co., Ltd. 2024 Annual Report
2024 Annual Report Summary
Haichuang Pharmaceutical (688302.SH) announced its 2024 annual performance, with a net loss attributable to the parent company of 0.199 billion yuan, a reduced loss.
Haichuang Pharmaceutical (688302.SH) released its annual report for 2024, with the company's revenue for the year 2024 at 36...
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
